Annual EBITDA:
$21.46B+$5.29B(+32.76%)Summary
- As of today, NVO annual EBITDA is $21.46 billion, with the most recent change of +$5.29 billion (+32.76%) on December 31, 2024.
- During the last 3 years, NVO annual EBITDA has risen by +$11.23 billion (+109.90%).
- NVO annual EBITDA is now at all-time high.
Performance
NVO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$4.94B-$882.57M(-15.16%)Summary
- As of today, NVO quarterly EBITDA is $4.94 billion, with the most recent change of -$882.57 million (-15.16%) on September 30, 2025.
- Over the past year, NVO quarterly EBITDA has dropped by -$370.94 million (-6.98%).
- NVO quarterly EBITDA is now -21.08% below its all-time high of $6.26 billion, reached on December 31, 2024.
Performance
NVO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$23.04B-$370.94M(-1.58%)Summary
- As of today, NVO TTM EBITDA is $23.04 billion, with the most recent change of -$370.94 million (-1.58%) on September 30, 2025.
- Over the past year, NVO TTM EBITDA has increased by +$3.33 billion (+16.90%).
- NVO TTM EBITDA is now -1.58% below its all-time high of $23.41 billion, reached on June 30, 2025.
Performance
NVO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NVO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +32.8% | -7.0% | +16.9% |
| 3Y3 Years | +109.9% | +64.7% | +103.2% |
| 5Y5 Years | +147.9% | +112.5% | +155.1% |
NVO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +109.9% | -21.1% | +92.8% | -1.6% | +103.2% |
| 5Y | 5-Year | at high | +147.9% | -21.1% | +147.7% | -1.6% | +155.1% |
| All-Time | All-Time | at high | >+9999.0% | -21.1% | +369.3% | -1.6% | +2893.3% |
NVO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $4.94B(-15.2%) | $23.04B(-1.6%) |
| Jun 2025 | - | $5.82B(-3.1%) | $23.41B(+3.8%) |
| Mar 2025 | - | $6.01B(-4.0%) | $22.54B(+4.0%) |
| Dec 2024 | $21.46B(+32.8%) | $6.26B(+17.9%) | $21.68B(+10.0%) |
| Sep 2024 | - | $5.31B(+7.1%) | $19.71B(+5.5%) |
| Jun 2024 | - | $4.96B(-3.5%) | $18.68B(+6.6%) |
| Mar 2024 | - | $5.14B(+19.9%) | $17.53B(+8.0%) |
| Dec 2023 | $16.16B(+41.2%) | $4.29B(+0.2%) | $16.23B(+11.9%) |
| Sep 2023 | - | $4.28B(+12.4%) | $14.50B(+9.7%) |
| Jun 2023 | - | $3.81B(-1.0%) | $13.22B(+7.9%) |
| Mar 2023 | - | $3.85B(+50.1%) | $12.25B(+6.7%) |
| Dec 2022 | $11.45B(+12.0%) | $2.56B(-14.6%) | $11.48B(+1.3%) |
| Sep 2022 | - | $3.00B(+5.5%) | $11.34B(+3.5%) |
| Jun 2022 | - | $2.84B(-7.6%) | $10.95B(+2.5%) |
| Mar 2022 | - | $3.08B(+27.3%) | $10.68B(+4.4%) |
| Dec 2021 | $10.22B(+12.5%) | $2.42B(-7.7%) | $10.24B(+4.3%) |
| Sep 2021 | - | $2.62B(+1.8%) | $9.81B(+3.1%) |
| Jun 2021 | - | $2.57B(-2.2%) | $9.52B(+4.1%) |
| Mar 2021 | - | $2.63B(+31.9%) | $9.15B(+0.9%) |
| Dec 2020 | $9.08B(+4.9%) | $1.99B(-14.2%) | $9.06B(+0.4%) |
| Sep 2020 | - | $2.33B(+5.9%) | $9.03B(+1.1%) |
| Jun 2020 | - | $2.20B(-13.8%) | $8.93B(+0.5%) |
| Mar 2020 | - | $2.55B(+30.0%) | $8.89B(+2.9%) |
| Dec 2019 | $8.66B(+9.3%) | $1.96B(-11.8%) | $8.63B(+1.1%) |
| Sep 2019 | - | $2.22B(+3.3%) | $8.53B(+3.5%) |
| Jun 2019 | - | $2.15B(-6.2%) | $8.25B(+1.7%) |
| Mar 2019 | - | $2.29B(+23.2%) | $8.11B(+2.2%) |
| Dec 2018 | $7.92B(+2.1%) | $1.86B(-3.9%) | $7.93B(+2.0%) |
| Sep 2018 | - | $1.94B(-3.7%) | $7.78B(-0.1%) |
| Jun 2018 | - | $2.01B(-5.0%) | $7.78B(-0.9%) |
| Mar 2018 | - | $2.12B(+23.9%) | $7.85B(+1.6%) |
| Dec 2017 | $7.75B(+2.5%) | $1.71B(-12.2%) | $7.73B(-0.8%) |
| Sep 2017 | - | $1.95B(-6.5%) | $7.79B(+0.1%) |
| Jun 2017 | - | $2.08B(+4.3%) | $7.79B(+1.3%) |
| Mar 2017 | - | $2.00B(+12.7%) | $7.69B(+1.7%) |
| Dec 2016 | $7.56B(+4.0%) | $1.77B(-8.8%) | $7.57B(+0.0%) |
| Sep 2016 | - | $1.94B(-2.0%) | $7.56B(+1.3%) |
| Jun 2016 | - | $1.98B(+6.0%) | $7.46B(+1.2%) |
| Mar 2016 | - | $1.87B(+5.8%) | $7.37B(+1.3%) |
| Dec 2015 | $7.27B(+10.3%) | $1.77B(-4.2%) | $7.27B(+2.6%) |
| Sep 2015 | - | $1.85B(-2.4%) | $7.09B(+3.2%) |
| Jun 2015 | - | $1.89B(+6.7%) | $6.87B(+3.0%) |
| Mar 2015 | - | $1.77B(+12.0%) | $6.67B(+3.3%) |
| Dec 2014 | $6.59B(+10.5%) | $1.58B(-2.6%) | $6.45B(+2.0%) |
| Sep 2014 | - | $1.62B(-3.9%) | $6.32B(+1.9%) |
| Jun 2014 | - | $1.69B(+8.6%) | $6.21B(+1.6%) |
| Mar 2014 | - | $1.56B(+7.1%) | $6.11B(+2.1%) |
| Dec 2013 | $5.96B(+10.0%) | $1.45B(-3.5%) | $5.98B(+0.5%) |
| Sep 2013 | - | $1.51B(-5.3%) | $5.95B(+1.9%) |
| Jun 2013 | - | $1.59B(+11.3%) | $5.84B(+3.3%) |
| Mar 2013 | - | $1.43B(+0.6%) | $5.65B(+4.1%) |
| Dec 2012 | $5.42B(+18.3%) | $1.42B(+1.7%) | $5.43B(+4.2%) |
| Sep 2012 | - | $1.40B(-0.6%) | $5.21B(+4.8%) |
| Jun 2012 | - | $1.41B(+16.4%) | $4.97B(+5.3%) |
| Mar 2012 | - | $1.21B(+0.7%) | $4.72B(+2.8%) |
| Dec 2011 | $4.58B(+24.6%) | $1.20B(+3.5%) | $4.59B(+7.7%) |
| Sep 2011 | - | $1.16B(+0.3%) | $4.26B(+4.5%) |
| Jun 2011 | - | $1.16B(+7.2%) | $4.08B(+5.8%) |
| Mar 2011 | - | $1.08B(+24.0%) | $3.86B(+5.4%) |
| Dec 2010 | $3.68B(+14.9%) | $869.91M(-10.8%) | $3.66B(+3.1%) |
| Sep 2010 | - | $975.07M(+4.4%) | $3.55B(+3.6%) |
| Jun 2010 | - | $934.28M(+6.2%) | $3.43B(+3.1%) |
| Mar 2010 | - | $879.92M(+15.7%) | $3.32B(+3.9%) |
| Dec 2009 | $3.20B(+9.8%) | $760.29M(-10.8%) | $3.20B(+1.7%) |
| Sep 2009 | - | $852.21M(+2.5%) | $3.15B(+3.0%) |
| Jun 2009 | - | $831.09M(+9.8%) | $3.06B(+3.4%) |
| Mar 2009 | - | $756.67M(+7.0%) | $2.96B(+3.2%) |
| Dec 2008 | $2.92B(+31.3%) | $706.95M(-7.1%) | $2.86B(-0.8%) |
| Sep 2008 | - | $761.33M(+4.1%) | $2.89B(+9.8%) |
| Jun 2008 | - | $731.65M(+10.2%) | $2.63B(+5.7%) |
| Mar 2008 | - | $663.80M(-9.0%) | $2.49B(+8.2%) |
| Dec 2007 | $2.22B(+20.0%) | $729.34M(+44.8%) | $2.30B(+13.9%) |
| Sep 2007 | - | $503.57M(-14.7%) | $2.02B(-1.1%) |
| Jun 2007 | - | $590.68M(+24.5%) | $2.04B(+3.1%) |
| Mar 2007 | - | $474.39M(+5.8%) | $1.98B(+5.3%) |
| Dec 2006 | $1.85B(+15.4%) | $448.42M(-14.8%) | $1.88B(+3.6%) |
| Sep 2006 | - | $526.59M(-0.5%) | $1.81B(+5.3%) |
| Jun 2006 | - | $528.98M(+41.2%) | $1.72B(+5.5%) |
| Mar 2006 | - | $374.60M(-2.3%) | $1.63B(+5.8%) |
| Dec 2005 | $1.60B(+11.7%) | $383.35M(-12.1%) | $1.54B(+22.9%) |
| Sep 2005 | - | $436.04M(-0.9%) | $1.26B(+37.3%) |
| Jun 2005 | - | $439.90M(+54.3%) | $915.39M(+70.1%) |
| Mar 2005 | - | $285.11M(+197.9%) | $538.15M(+69.9%) |
| Dec 2004 | $1.44B | $95.71M(+1.1%) | $316.78M(-38.7%) |
| Sep 2004 | - | $94.67M(+51.1%) | $516.56M(-25.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $62.66M(-1.7%) | $693.43M(-22.9%) |
| Mar 2004 | - | $63.74M(-78.4%) | $899.60M(-14.4%) |
| Dec 2003 | $1.05B(+30.6%) | $295.49M(+8.8%) | $1.05B(+5.9%) |
| Sep 2003 | - | $271.54M(+1.0%) | $991.57M(+4.9%) |
| Jun 2003 | - | $268.83M(+25.3%) | $945.59M(+6.1%) |
| Mar 2003 | - | $214.63M(-9.3%) | $890.93M(+10.2%) |
| Dec 2002 | $801.12M(+14.5%) | $236.57M(+4.9%) | $808.68M(+198.1%) |
| Sep 2002 | - | $225.56M(+5.3%) | -$824.64M(-225.4%) |
| Jun 2002 | - | $214.17M(+61.8%) | -$253.40M(-223.6%) |
| Mar 2002 | - | $132.39M(+109.5%) | $205.10M(-72.1%) |
| Dec 2001 | $699.61M(+7.2%) | -$1.40B(-275.3%) | $734.28M(+64.1%) |
| Sep 2001 | - | $796.80M(+18.5%) | $447.56M(-70.4%) |
| Jun 2001 | - | $672.68M(+1.7%) | $1.51B(-8.4%) |
| Mar 2001 | - | $661.56M(+139.3%) | $1.65B(-4.4%) |
| Dec 2000 | $652.70M(-9.3%) | -$1.68B(-190.4%) | $1.73B(+3.2%) |
| Sep 2000 | - | $1.86B(+129.8%) | $1.67B(+164.8%) |
| Jun 2000 | - | $810.58M(+9.9%) | $631.91M(+18.0%) |
| Mar 2000 | - | $737.25M(+142.4%) | $535.67M(+7.6%) |
| Dec 1999 | $719.42M(+38.6%) | -$1.74B(-311.5%) | $497.68M(+24.2%) |
| Sep 1999 | - | $821.66M(+15.0%) | $400.56M(+21.5%) |
| Jun 1999 | - | $714.35M(+2.2%) | $329.62M(+16.3%) |
| Mar 1999 | - | $699.25M(+138.1%) | $283.42M(+49.8%) |
| Dec 1998 | $519.22M(-1.0%) | -$1.83B(-344.4%) | $189.17M(-64.5%) |
| Sep 1998 | - | $750.72M(+12.4%) | $533.53M(+30.1%) |
| Jun 1998 | - | $668.15M(+10.4%) | $410.22M(+9.7%) |
| Mar 1998 | - | $605.00M(+140.6%) | $373.83M(+8.7%) |
| Dec 1997 | $524.72M(+0.0%) | -$1.49B(-337.5%) | $343.90M(-1.1%) |
| Sep 1997 | - | $627.41M(-0.7%) | $347.59M(-2.2%) |
| Jun 1997 | - | $631.76M(+9.9%) | $355.50M(+10.7%) |
| Mar 1997 | - | $575.07M(+138.7%) | $321.20M(-8.5%) |
| Dec 1996 | $524.51M(-2.5%) | -$1.49B(-334.0%) | $351.00M(+13.0%) |
| Sep 1996 | - | $635.32M(+6.3%) | $310.67M(+22.2%) |
| Jun 1996 | - | $597.46M(-1.2%) | $254.25M(-17.8%) |
| Mar 1996 | - | $604.87M(+139.6%) | $309.26M(+10.6%) |
| Dec 1995 | $538.18M(+22.2%) | -$1.53B(-363.8%) | $279.55M(-39.6%) |
| Sep 1995 | - | $578.90M(-11.3%) | $462.93M(+7.2%) |
| Jun 1995 | - | $652.47M(+13.4%) | $431.98M(+41.5%) |
| Mar 1995 | - | $575.16M(+142.8%) | $305.32M(+57.9%) |
| Dec 1994 | $440.30M(+16.0%) | -$1.34B(-345.2%) | $193.31M(-61.2%) |
| Sep 1994 | - | $547.95M(+4.2%) | $498.12M(+20.1%) |
| Jun 1994 | - | $525.81M(+13.5%) | $414.84M(+11.2%) |
| Mar 1994 | - | $463.15M(+144.6%) | $373.05M(+13.9%) |
| Dec 1993 | $379.63M(+6.8%) | -$1.04B(-323.6%) | $327.44M(+42.2%) |
| Sep 1993 | - | $464.66M(-4.0%) | $230.21M(+4.7%) |
| Jun 1993 | - | $484.02M(+15.9%) | $219.90M(+17.9%) |
| Mar 1993 | - | $417.53M(+136.8%) | $186.47M(-3.2%) |
| Dec 1992 | $355.62M(+27.5%) | -$1.14B(-350.0%) | $192.69M(-58.0%) |
| Sep 1992 | - | $454.35M(+0.8%) | $458.91M(+27.5%) |
| Jun 1992 | - | $450.60M(+6.3%) | $359.94M(+45.3%) |
| Mar 1992 | - | $423.75M(+148.7%) | $247.65M(+17.7%) |
| Dec 1991 | $278.92M(+33.3%) | -$869.78M(-344.7%) | $210.43M(-4.3%) |
| Sep 1991 | - | $355.38M(+5.1%) | $219.95M(+10.7%) |
| Jun 1991 | - | $338.30M(-12.5%) | $198.62M(+11.5%) |
| Mar 1991 | - | $386.54M(+144.9%) | $178.09M(+99.9%) |
| Dec 1990 | $209.25M(+17.3%) | -$860.27M(-357.5%) | $89.08M(-72.2%) |
| Sep 1990 | - | $334.06M(+5.1%) | $320.60M(+45.5%) |
| Jun 1990 | - | $317.76M(+6.8%) | $220.29M(+61.6%) |
| Mar 1990 | - | $297.53M(+147.3%) | $136.35M(+19.6%) |
| Dec 1989 | $178.41M(+18.3%) | -$628.74M(-369.0%) | $113.96M(-61.5%) |
| Sep 1989 | - | $233.75M(-0.0%) | $295.66M(+19.7%) |
| Jun 1989 | - | $233.82M(-15.0%) | $247.03M(+9.3%) |
| Mar 1989 | - | $275.14M(+161.5%) | $226.03M(+66.2%) |
| Dec 1988 | $150.80M(+35.3%) | -$447.04M(-341.5%) | $136.02M(+8.2%) |
| Sep 1988 | - | $185.12M(-13.0%) | $125.67M(+3.7%) |
| Jun 1988 | - | $212.81M(+15.0%) | $121.19M(+51.2%) |
| Mar 1988 | - | $185.13M(+140.5%) | $80.13M(+12.1%) |
| Dec 1987 | $111.46M(+7.1%) | -$457.39M(-353.2%) | $71.49M(-64.6%) |
| Sep 1987 | - | $180.64M(+5.2%) | $202.13M(+34.0%) |
| Jun 1987 | - | $171.75M(-2.7%) | $150.89M(+33.6%) |
| Mar 1987 | - | $176.49M(+154.0%) | $112.91M(+105.3%) |
| Dec 1986 | $104.09M(+24.9%) | -$326.75M(-352.5%) | $55.00M(-56.7%) |
| Sep 1986 | - | $129.40M(-3.3%) | $126.97M(+35.8%) |
| Jun 1986 | - | $133.77M(+12.8%) | $93.51M(+70.1%) |
| Mar 1986 | - | $118.58M(+146.5%) | $54.98M(+90.2%) |
| Dec 1985 | $83.32M(-8.9%) | -$254.79M(-365.6%) | $28.90M(-65.6%) |
| Sep 1985 | - | $95.94M(+0.7%) | $83.91M(+5.5%) |
| Jun 1985 | - | $95.24M(+3.0%) | $79.51M(+5.4%) |
| Mar 1985 | - | $92.51M(+146.3%) | $75.44M(+0.5%) |
| Dec 1984 | $91.50M(-14.1%) | -$199.77M(-318.2%) | $75.07M(-72.7%) |
| Sep 1984 | - | $91.54M(+0.4%) | $274.84M(+49.9%) |
| Jun 1984 | - | $91.16M(-1.1%) | $183.30M(+98.9%) |
| Mar 1984 | - | $92.14M | $92.14M |
| Dec 1983 | $106.56M(+15.3%) | - | - |
| Dec 1982 | $92.38M(+17.4%) | - | - |
| Dec 1981 | $78.71M(+20.2%) | - | - |
| Dec 1980 | $65.47M | - | - |
FAQ
- What is Novo Nordisk A/S annual EBITDA?
- What is the all-time high annual EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual EBITDA year-on-year change?
- What is Novo Nordisk A/S quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly EBITDA year-on-year change?
- What is Novo Nordisk A/S TTM EBITDA?
- What is the all-time high TTM EBITDA for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM EBITDA year-on-year change?
What is Novo Nordisk A/S annual EBITDA?
The current annual EBITDA of NVO is $21.46B
What is the all-time high annual EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual EBITDA is $21.46B
What is Novo Nordisk A/S annual EBITDA year-on-year change?
Over the past year, NVO annual EBITDA has changed by +$5.29B (+32.76%)
What is Novo Nordisk A/S quarterly EBITDA?
The current quarterly EBITDA of NVO is $4.94B
What is the all-time high quarterly EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly EBITDA is $6.26B
What is Novo Nordisk A/S quarterly EBITDA year-on-year change?
Over the past year, NVO quarterly EBITDA has changed by -$370.94M (-6.98%)
What is Novo Nordisk A/S TTM EBITDA?
The current TTM EBITDA of NVO is $23.04B
What is the all-time high TTM EBITDA for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM EBITDA is $23.41B
What is Novo Nordisk A/S TTM EBITDA year-on-year change?
Over the past year, NVO TTM EBITDA has changed by +$3.33B (+16.90%)